Cleared Special

K072215 - TITANIUM POWERPORT ISP IMPLANTED PORT (FDA 510(k) Clearance)

Nov 2007
Decision
84d
Days
Class 2
Risk

K072215 is an FDA 510(k) clearance for the TITANIUM POWERPORT ISP IMPLANTED PORT. This device is classified as a Port & Catheter, Implanted, Subcutaneous, Intravascular (Class II - Special Controls, product code LJT).

Submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on November 1, 2007, 84 days after receiving the submission on August 9, 2007.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5965.

Submission Details

510(k) Number K072215 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 09, 2007
Decision Date November 01, 2007
Days to Decision 84 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code LJT — Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5965

Similar Devices — LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

Vaccess™ CT Low-Profile Power-Injectable Implantable Port
K252478 · Bard Access Systems, Inc. · Sep 2025
PowerPort™ isp Implantable Port
K251253 · Bard Access Systems, Inc. · Jun 2025
PowerPort™ ClearVUE™ Slim Implantable Ports and PowerPort™ ClearVUE™ Slim Implantable Ports
K242328 · Bard Access Systems, Inc. · Oct 2024
PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port
K232737 · Bard Peripheral Vascular, Inc. · Dec 2023